资讯

Areteia Therapeutics Announces Positive Topline Results from the First Phase III Study of ...

Areteia Therapeutics, Inc. ("Areteia") today announced positive results from the Phase III EXHALE-4 efficacy and safety study of dexpramipexole as an add-on oral therapy in participants with ...

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board

Thomas Schall Thomas Schall, Chariman of the Board of Directors of Immuneering NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ...